June 19, 2025 (press release) –
Mitsui Chemicals, Inc. (Tokyo: 4183; President & CEO: HASHIMOTO Osamu) today announced that it has invested in Hoxton Farms Ltd (London, UK; CEO: Max Jamilly), a company developing cultivated fats for the next generation of food products, via 321FORCE Global Innovation Fund L.P. (321FORCE™; managed by Global Brain Corporation).
About Hoxton Farms
Hoxton Farms is a company that combines molecular biology, mathematical modeling and machine learning to produce fats cultured from stem cells. The company’s proprietary scale-out manufacturing process reduces the production costs and expansion risks involved in mass production. Cultured fat is an ingredient that gives meat alternatives the flavor and juicy mouthfeel of meat. By applying it to plant-based and cultured meat, Hoxton Farms aims to contribute to the spread of delicious and sustainable meat alternatives.
Mitsui Chemicals will collaborate with Hoxton Farms to drive next-gen biomanufacturing by exploring opportunities to accelerate the scale-up and commercialization of cultivated fats and other cell culture product manufacturing technologies in a variety of fields, including food, cosmetics, pharmaceuticals and sustainable materials.
Going forward, 321FORCE™ will continue to leverage joint development efforts with the Mitsui Chemicals Group and startups in order to promptly grasp social issues and needs, and create solutions in response, as well as seeking to expand new business portfolios and contribute to sustainable growth.
* All content is copyrighted by Industry Intelligence, or the original respective author or source. You may not recirculate, redistribute or publish the analysis and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.